Niwrowyddorau Pediatrig

Teitl
Ataluren for Treating Duchenne Muscular Dystrophy with a Nonsense Mutation in the Dystrophin Gene Policy Position Statement (PP118), July 2023 (Saesneg) (PDF, 217Kb)
Atidarsagene Autotemcel for Treating Metachromatic Leukodystrophy in Children, Policy Position Statement, (PP257), April 2023 (Saesneg) (PDF, 180Kb)
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (PP281) February 2027 (Saesneg) (PDF, 212Kb)
Selective Dorsal Rhizotomy (SDR) for the treatment of spasticity in cerebral palsy in children aged 3-9 years, Policy Position Statement (PP245), March 2024 (Saesneg) (PDF, 975Kb)
Specialised Paediatric Neurological Rehabilitation, Commissioning Policy (CP160), November 2024 (Saesneg) (PDF, 385Kb)